GlassScriptPhysician profile
Brad Gollinger
NPI 1699779678
$5,706.76
in general payments reported to CMS, 2019-2025
19 companies · $424 in 2025
The $424 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $290 · 2020: $512 · 2021: $427 · 2022: $882 · 2023: $2,380 · 2024: $792 · 2025: $424.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,119 · Travel and Lodging: $1,377 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,118.90 |
| Travel and Lodging | $1,376.75 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $3,138.58 | 2019-2025 | Air Optix, Dailies Aqua Comfort Plus, Precision 1 |
| Coopervision INC. | $1,034.92 | 2019-2025 | Myday Contact Lens, Misight Contact Lens, Clariti Contact Lens |
| Bausch & Lomb Americas INC. | $371.18 | 2022-2025 | Infuse, Miebo, Xiidra |
| Johnson & Johnson Vision Care, INC. | $287.59 | 2019-2025 | Acuvue |
| Sun Pharmaceutical Industries INC. | $223.59 | 2021-2025 | Cequa |
| Abbvie INC. | $108.08 | 2022 | |
| Novartis Pharmaceuticals Corporation | $99.60 | 2019-2023 | |
| Aerie Pharmaceuticals, INC. | $66.33 | 2021 | |
| Visioneering Technologies, INC. | $62.92 | 2019-2020 | |
| Tarsus Pharmaceuticals, INC. | $59.72 | 2024-2025 | Xdemvy |
| Sight Sciences, INC. | $54.59 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $44.76 | 2019-2021 | |
| Eyevance Pharmaceuticals LLC | $35.35 | 2020-2021 | |
| Allergan, INC. | $25.02 | 2022 | |
| Shire North American Group INC | $23.90 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spark Therapeutics, INC. | $20.85 | 2022 | |
| Lkc Technologies, INC. | $20.19 | 2024 | |
| Oyster Point Pharma, INC. | $16.67 | 2022 | |
| Glaukos Corporation | $12.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brad Gollinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.